Gordon Guyatt the winner of a 200,000 prize worth about $280,000 for his pioneering work promoting quality in medical research leading to better patient care
About the Study In the present study, researchers investigated associations between GLP-1RA use and major cardiovascular and thromboembolic events in adults with obesity and AID
Administration of exogenous carnitine as an adjunct to VPA therapy is thought to restore beta-oxidation to mitochondria cells of the liver, accept toxic acyl moieties from CoA, and relieve the inhibition of urea synthesis.[3] However, our findings suggested that the effective utilization of levocarnitine transport into mitochondria, which may be individually different, might play an important role to lead these favorable processes
Further exploration is needed to understand the regulation of mitochondrial iron content and the interaction among MTFT, Fe-S cluster, and heme [78, 84]